Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Inventory Average: 2019-2025

Historic Inventory Average for Organogenesis Holdings (ORGO) over the last 7 years, with Sep 2025 value amounting to $36.3 million.

  • Organogenesis Holdings' Inventory Average rose 34.69% to $36.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.3 million, marking a year-over-year increase of 34.69%. This contributed to the annual value of $27.2 million for FY2024, which is 2.71% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Inventory Average of $36.3 million as of Q3 2025, which was up 16.42% from $31.2 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Inventory Average high stood at $36.3 million for Q3 2025, and its period low was $23.0 million during Q2 2022.
  • Its 3-year average for Inventory Average is $28.1 million, with a median of $27.3 million in 2024.
  • As far as peak fluctuations go, Organogenesis Holdings' Inventory Average decreased by 20.50% in 2022, and later spiked by 34.69% in 2025.
  • Organogenesis Holdings' Inventory Average (Quarterly) stood at $27.3 million in 2021, then dropped by 9.26% to $24.7 million in 2022, then grew by 13.53% to $28.1 million in 2023, then decreased by 5.17% to $26.6 million in 2024, then soared by 34.69% to $36.3 million in 2025.
  • Its Inventory Average was $36.3 million in Q3 2025, compared to $31.2 million in Q2 2025 and $27.8 million in Q1 2025.